[Testing of the effect of Imposit throat tablets in double-blind test].
D000293:Adolescent; D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006096:Gramicidin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy
D062365:Aminobenzoates; D001592:Benzyl Alcohols; D001593:Benzyl Compounds; D004338:Drug Combinations; D011726:Pyridinium Compounds; D006096:Gramicidin; D002594:Cetylpyridinium
Zur Prüfung der Wirkung von Imposit1-Halstabletten im Doppelblindversuch